Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: Stock Traders Daily
Provider: Wright Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Tandem Diabetes Care Inc gives FY 2014 revenue guidance in line with analysts' estimates

Thursday, 6 Mar 2014 04:15pm EST 

Tandem Diabetes Care Inc:Expects FY 2014 sales to be in the range of $48.0 million to $54.0 million.FY 2014 revenue of $52 million - Thomson Reuters I/B/E/S. 

Company Quote

-0.15 -1.16%
26 Dec 2014